Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 6
1972 3
1974 3
1975 1
1976 1
1980 2
1981 2
1982 2
1983 6
1984 4
1985 1
1986 2
1987 1
1988 3
1989 1
1990 3
1991 4
1992 3
1993 4
1994 4
1995 3
1996 3
1998 2
1999 2
2000 8
2001 4
2002 7
2003 8
2004 5
2005 7
2006 10
2007 14
2008 13
2009 13
2010 6
2011 17
2012 10
2013 12
2014 4
2015 3
2016 5
2017 2
2018 6
2019 11
2020 9
2021 10
2022 20
2023 21
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Schizophrenia.
Vita A, Barlati S, De Peri L, Deste G, Sacchetti E. Vita A, et al. Among authors: barlati s. Lancet. 2016 Sep 24;388(10051):1280. doi: 10.1016/S0140-6736(16)31674-9. Lancet. 2016. PMID: 27673467 No abstract available.
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Martinotti G, Dell'Osso B, Di Lorenzo G, Maina G, Bertolino A, Clerici M, Barlati S, Rosso G, Di Nicola M, Marcatili M, d'Andrea G, Cavallotto C, Chiappini S, De Filippis S, Nicolò G, De Fazio P, Andriola I, Zanardi R, Nucifora D, Di Mauro S, Bassetti R, Pettorruso M, McIntyre RS, Sensi SL, di Giannantonio M, Vita A; REAL-ESK Study Group. Martinotti G, et al. Among authors: barlati s. Bipolar Disord. 2023 May;25(3):233-244. doi: 10.1111/bdi.13296. Epub 2023 Jan 18. Bipolar Disord. 2023. PMID: 36636839 Free article.
Recovery from schizophrenia: is it possible?
Vita A, Barlati S. Vita A, et al. Among authors: barlati s. Curr Opin Psychiatry. 2018 May;31(3):246-255. doi: 10.1097/YCO.0000000000000407. Curr Opin Psychiatry. 2018. PMID: 29474266 Review.
Schizophrenia during the COVID-19 pandemic.
Barlati S, Nibbio G, Vita A. Barlati S, et al. Curr Opin Psychiatry. 2021 May 1;34(3):203-210. doi: 10.1097/YCO.0000000000000702. Curr Opin Psychiatry. 2021. PMID: 33587494 Free PMC article. Review.
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates.
Vita A, Minelli A, Barlati S, Deste G, Giacopuzzi E, Valsecchi P, Turrina C, Gennarelli M. Vita A, et al. Among authors: barlati s. Front Pharmacol. 2019 Apr 16;10:402. doi: 10.3389/fphar.2019.00402. eCollection 2019. Front Pharmacol. 2019. PMID: 31040787 Free PMC article. Review.
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).
Pettorruso M, Guidotti R, d'Andrea G, De Risio L, D'Andrea A, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, De Filippis S, Di Nicola M, Andriola I, Marcatili M, Nicolò G, Martiadis V, Bassetti R, Nucifora D, De Fazio P, Rosenblat JD, Clerici M, Maria Dell'Osso B, Vita A, Marzetti L, Sensi SL, Di Lorenzo G, McIntyre RS, Martinotti G; REAL-ESK Study Group. Pettorruso M, et al. Among authors: barlati s. Psychiatry Res. 2023 Sep;327:115378. doi: 10.1016/j.psychres.2023.115378. Epub 2023 Jul 28. Psychiatry Res. 2023. PMID: 37574600 Free article.
273 results